Inspired by the close association between cyclooxygenase-2 (COX-2) and tumor-associated angiogenesis, as well as tumor matrix formation, our group explored the tumor microenvironment modulation effect of celecoxib, a special COX-2 inhibitor widely used in clinics. The gene discussed is PTGS2; the disease is neoplasm.